BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/2/2024 9:42:16 AM | Browse: 151 | Download: 639
 |
Received |
|
2023-10-16 14:46 |
 |
Peer-Review Started |
|
2023-10-16 14:48 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2023-12-06 05:49 |
 |
Revised |
|
2023-12-06 12:16 |
 |
Second Decision |
|
2024-01-08 03:09 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-01-08 07:56 |
 |
Articles in Press |
|
2024-01-08 07:56 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-01-29 00:26 |
 |
Publish the Manuscript Online |
|
2024-02-02 09:42 |
ISSN |
1948-5204 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Observational Study |
Article Title |
Prognostic value of circulating tumor cells combined with neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Jia-Li Chen, Lu Guo, Zhen-Ying Wu, Kun He, Han Li, Chi Yang and Yun-Wei Han |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Yun-Wei Han, MD, PhD, Professor, Researcher, Department of Oncology, The Affiliated Hospital of Southwest Medical University, No. 25 Taiping Street, Jiangyang District, Luzhou 646000, Sichuan Province, China. lanpaoxiansheng@126.com |
Key Words |
Circulating tumor cells; Neutrophil–lymphocyte ratio; Hepatocellular carcinoma; Prognosis; Survival; Marker |
Core Tip |
This study evaluates whether the combination of programmed death-ligand 1 on circulating tumor cells (CTCs) and the neutrophil-lymphocyte ratio can serve as a biomarker for predicting the prognosis of immune combination targeted therapy in hepatocellular carcinoma. Our study suggests the combination of CTC and neutrophil-to-lymphocyte ratio (NLR) scores as a new index for predicting survival in patients with hepatocellular carcinoma (HCC). HCC patients may benefit from pre-treatment assessment of their CTC-NLR scores for risk classification and clinical decision-making. |
Publish Date |
2024-02-02 09:42 |
Citation |
Chen JL, Guo L, Wu ZY, He K, Li H, Yang C, Han YW. Prognostic value of circulating tumor cells combined with neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma. World J Gastrointest Oncol 2024; 16(2): 372-385 |
URL |
https://www.wjgnet.com/1948-5204/full/v16/i2/372.htm |
DOI |
https://dx.doi.org/10.4251/wjgo.v16.i2.372 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345